Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wangli Mei

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cancer|May 25, 2026
Integrative Machine Learning Framework Revealing TRPM4-Associated Signatures and Identifying SPATA6 as a Potential Biomarker in Prostate CancerHang Zhou, Wangli Mei, Jichen Wang, et al.
Cytojournal|November 11, 2025
Different metabolic paradigms and distribution of regulatory T cells between primary and lymph node metastasis prostate cancerWangli Mei, Shuai Liu, Mengyu Wei, et al.
Computational Biology and Chemistry|July 8, 2026
Identification and verification of immunogenic cell death-related signatures derived from bone metastasis of prostate cancer based on multi-omics and machine learning algorithmsWeiguo Ma, Wangli Mei, Lei Guang, et al.
Frontiers in Oncology|July 29, 2025
Characteristic metabolite profile of 10 colorectal cancer-related bacteriaYongqiang Liu, Wangli Mei, Xinyan Huang, et al.
Frontiers in Oncology|October 24, 2022
Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancerWangli Mei, Liang Jin, Bihui Zhang, et al.
Cell Death & Disease|April 24, 2025
BCAT2 binding to PCBP1 regulates the PI3K/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancerWangli Mei, Mengyu Wei, Chaozhi Tang, et al.
Frontiers in Oncology|October 3, 2022
Ubiquitin-related lncRNAs: The new tool for prognosis prediction in prostate cancerXiang Liu, Wangli Mei, Liang Jin, et al.
International Journal of Oncology|December 1, 2023
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathwayXianchao Sun, Shiyong Xin, Ying Zhang, et al.
International Journal of Oncology|July 29, 2022
Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathwayXianchao Sun, Shiyong Xin, Ying Zhang, et al.
Frontiers in Immunology|October 7, 2022
Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancerLiang Jin, Wangli Mei, Xiang Liu, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cancer|May 25, 2026
Integrative Machine Learning Framework Revealing TRPM4-Associated Signatures and Identifying SPATA6 as a Potential Biomarker in Prostate CancerHang Zhou, Wangli Mei, Jichen Wang, et al.
Cytojournal|November 11, 2025
Different metabolic paradigms and distribution of regulatory T cells between primary and lymph node metastasis prostate cancerWangli Mei, Shuai Liu, Mengyu Wei, et al.
Computational Biology and Chemistry|July 8, 2026
Identification and verification of immunogenic cell death-related signatures derived from bone metastasis of prostate cancer based on multi-omics and machine learning algorithmsWeiguo Ma, Wangli Mei, Lei Guang, et al.
Frontiers in Oncology|July 29, 2025
Characteristic metabolite profile of 10 colorectal cancer-related bacteriaYongqiang Liu, Wangli Mei, Xinyan Huang, et al.
Frontiers in Oncology|October 24, 2022
Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancerWangli Mei, Liang Jin, Bihui Zhang, et al.
Cell Death & Disease|April 24, 2025
BCAT2 binding to PCBP1 regulates the PI3K/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancerWangli Mei, Mengyu Wei, Chaozhi Tang, et al.
Frontiers in Oncology|October 3, 2022
Ubiquitin-related lncRNAs: The new tool for prognosis prediction in prostate cancerXiang Liu, Wangli Mei, Liang Jin, et al.
International Journal of Oncology|December 1, 2023
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathwayXianchao Sun, Shiyong Xin, Ying Zhang, et al.
International Journal of Oncology|July 29, 2022
Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathwayXianchao Sun, Shiyong Xin, Ying Zhang, et al.
Frontiers in Immunology|October 7, 2022
Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancerLiang Jin, Wangli Mei, Xiang Liu, et al.
Pageof 3